Sponsored by:

Nuclear Medicine: Page 254

Study combines FDG-PET/CT with circulating tumor cell counts
By Wayne Forrest
Although FDG-PET/CT is useful for monitoring patients with bone metastases from breast cancer, additional prospective studies are needed to define the roles of FDG-PET/CT and circulating tumor cells in measuring the disease, according to a new study in the August issue of the Journal of Nuclear Medicine.
August 25, 2010
Nuclear breast imaging may have greater cancer risks
By Wayne Forrest
Breast-specific gamma imaging or positron emission mammography exams may increase a woman's risk of developing radiation-induced cancer, according to a special report published online August 24 and appearing in the October issue of Radiology.
August 23, 2010
AECL continues NRU maintenance
By AuntMinnie.com staff writers
Atomic Energy of Canada (AECL) plans to shut down its National Research Universal (NRU) reactor in Chalk River, Ontario, early this week to remove specialized instrumentation used in the facility's recent restart.
August 23, 2010
Naviscan touts study on dose for PEM scanner
By AuntMinnie.com staff writers
Research from the University of Washington in Seattle suggests that FDG dose for positron emission mammography (PEM) could be reduced by as much as 70% without altering image quality, according to a study being touted by PET developer Naviscan of San Diego.
August 23, 2010
Lantheus resumes TechneLite production
By AuntMinnie.com staff writers
Lantheus Medical Imaging has resumed the manufacture of its TechneLite technetium-99m generator, using molybdenum-99 from Atomic Energy of Canada's National Research Universal reactor.
August 23, 2010
Medrad signs Novation deal
By AuntMinnie.com staff writers
Contrast injector technology firm Medrad has inked a national supply contract for its Intego PET infusion system with group purchasing organization Novation.
August 22, 2010
Study: $6.6B molecular imaging market by 2014
By AuntMinnie.com staff writers
Cost savings from early disease detection and clinicians' demand for better, more accurate diagnostic tools will lead to 5.8% annual growth for molecular imaging devices, according to a new report by healthcare market research firm Kalorama Information of New York City.
August 22, 2010
Dual-tracer nuclear protocol finds high-risk heart patients
By Wayne Forrest
A nuclear medicine protocol with two radiopharmaceuticals can identify high-risk cardiac patients and help physicians determine which patients are best suited for implantable cardioverter defibrillator therapy, according to a study in the August issue of the Journal of Nuclear Medicine.
August 22, 2010
AECL produces first Mo-99 batch
By AuntMinnie.com staff writers
Atomic Energy of Canada (AECL) has taken the first batch of molybdenum-99 (Mo-99) from the National Research Universal nuclear reactor.
August 19, 2010
Cell>Point shows promising results with new cancer imaging agent
By Wayne Forrest
Radiopharmaceutical developer Cell>Point is moving toward a phase III clinical trial for its SPECT imaging agent after encouraging preliminary results showed the agent's ability to match FDG-PET in diagnosing and staging patients with cancer.
August 19, 2010
2010 08 13 17 11 26 403 Rollo Slide22 Ecdg Thumb
Positron to collaborate with Covidien
By AuntMinnie.com staff writers
Molecular imaging developer Positron has signed an agreement with healthcare technology firm Covidien.
August 18, 2010
Int'l Isotopes reports sluggish Q2
By AuntMinnie.com staff writers
Radioisotope manufacturer International Isotopes is blaming current economic conditions and lower bulk cobalt sales for a decline in revenue for the first six months of 2010.
August 17, 2010
Previous Page
Page 254 of 440
Next Page